Products for Research Use Only

P2Ca

CAT: 0804-HY-P0260Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P0260Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
P2Ca, an 8-mer peptide, is a ligand that is naturally processed and presented to the Ld-alloreactive T cell clone, 2C.
CAS Number
142606-55-1
UNSPSC
12352209
Target
Others
Type
Peptides
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/p2Ca.html
Solubility
H2O
Smiles
O=C([C@H]1N(CCC1)C([C@H](CO)NC([C@@H](N)CC(C)C)=O)=O)N[C@@H](CC2=CC=CC=C2)C(N3[C@@H](CCC3)C(N[C@H](C(N[C@@H](CC(O)=O)C(N[C@H](C(O)=O)CC(C)C)=O)=O)CC4=CC=CC=C4)=O)=O
Molecular Formula
C47H66N8O12
Molecular Weight
935.07
References & Citations
[1]Hornell TM, et al. Peptide length variants p2Ca and QL9 present distinct conformations to L (d) -specific T cells. J Immunol. 2001 Oct 15;167 (8) :4207-14.|[2]Connolly JM, et al. The peptide p2Ca is immunodominant in allorecognition of Ld by beta chain variable region V beta 8+ but not V beta 8- strains. Proc Natl Acad Sci U S A. 1994 Nov 22;91 (24) :11482-6.|[3]Tjoa BA, et al. Generation of cytotoxic T-lymphocytes to a self-peptide/class I complex: a model for peptide-mediated tumor rejection. Cancer Res. 1994 Jan 1;54 (1) :204-8.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported